Comparative Pharmacology
Head-to-head clinical analysis: BANAN versus CEFACLOR.
Peer-Reviewed Evidence
Head-to-head clinical analysis: BANAN versus CEFACLOR.
BANAN vs CEFACLOR
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
BANAN is a potassium-channel opener that hyperpolarizes smooth muscle cells, leading to vasodilation and reduced peripheral vascular resistance.
Bactericidal; inhibits cell wall synthesis by binding to penicillin-binding proteins (PBPs), disrupting peptidoglycan cross-linking.
500 mg orally twice daily for 7-14 days.
250-500 mg orally every 8 hours
None Documented
None Documented
2.5 hours (normal renal function); prolonged to 6-8 hours in severe renal impairment
Terminal elimination half-life: 0.5-1 hour; prolonged to 2-3 hours in renal impairment
Clinical Note
moderateCefaclor + Probenecid
"The serum concentration of Probenecid can be increased when it is combined with Cefaclor."
Clinical Note
moderateCefaclor + Picosulfuric acid
"The therapeutic efficacy of Picosulfuric acid can be decreased when used in combination with Cefaclor."
Clinical Note
moderateWarfarin + Cefaclor
"Warfarin may increase the anticoagulant activities of Cefaclor."
Clinical Note
moderatePhenprocoumon + Cefaclor
Renal: 70% unchanged; biliary: 20%; fecal: 10%
Renal: 60-85% unchanged in urine within 8 hours; biliary/fecal: minor, ~5%
Category C
Category A/B
Cephalosporin Antibiotic
Cephalosporin Antibiotic
"Phenprocoumon may increase the anticoagulant activities of Cefaclor."